試す 金 - 無料
A Booster Shot
Forbes India
|February 26, 2021
Increased outlays for health, ₹35,000 crore for Covid-19 vaccines to help cope with immediate needs in light of the pandemic and help prepare for future eventualities
FINANCE MINISTER
Nirmala Sitharaman earmarked ₹35,000 crore toward Covid-19 vaccines in Union Budget 2021. “I am committed to provide further funds if required,” she said, adding that two more vaccines will be rolled out soon. Currently, India has granted emergency use authorisation for Covaxin, developed by Hyderabad-based Bharat Biotech, and Covishield, manufactured by the Serum Institute of India in Pune.
このストーリーは、Forbes India の February 26, 2021 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Translate
Change font size
